Skip to main content

Hemrajani Rekha's Form 4 filing

Maxcyte, Inc.MXCT · filed Aug 27, 2025

Accession no.
0000905148-25-003155
Filed
Aug 27, 2025
Trade date
Jun 25, 2025
Filing delay
63 daysLate
Rule 10b5-1 plan
Checked

This filing lists 1 non-derivative transaction. Open-market sales total $22.3K. It was filed 63 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hemrajani RekhaCIK 0001771213Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 25, 2025Common StockSSaleDisposed−10,684$2.09F2−$22,329.5639,893Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.07 to $2.1212, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)